During the past decade, Cumberland Research Associates, LLC conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 29 clinical trials were completed, i.e. on average, 76.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 16 clinical trials were completed. i.e. 228.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cumberland Research Associates, LLC" #1 sponsor was "Gilead Sciences" with 10 trials, followed by "Allergan" with 5 trials sponsored, "Exact Sciences Corporation" with 4 trials sponsored, "Ferring Pharmaceuticals" with 4 trials sponsored and "Evoke Pharma" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cumberland Research Associates, LLC" #1 collaborator was "Allergan Sales, LLC" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Cumberland Research Associates, LLC" are "Gastroparesis" (6 trials), "Nonalcoholic Steatohepatitis" (6 trials), "Colorectal Cancer" (5 trials), "Diabetes Mellitus" (5 trials) and "Diabetic Gastroparesis" (4 trials). Many other conditions were trialed in "Cumberland Research Associates, LLC" in a lesser frequency.

Most popular intervention types in "Cumberland Research Associates, LLC" are "Drug" (53 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Relamorelin" (4 trials), "SEL" (3 trials), "Elobixibat 10 mg" (2 trials) and "HTD1801" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cumberland Research Associates, LLC" are 60 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cumberland Research Associates, LLC". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Cumberland Research Associates, LLC, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Cumberland Research Associates, LLC, 1 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".